These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 29579035)
21. Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials. Bailey CJ; Marx N Diabetes Obes Metab; 2019 Jan; 21(1):3-14. PubMed ID: 30091169 [TBL] [Abstract][Full Text] [Related]
22. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications. Heerspink HJ; Perkins BA; Fitchett DH; Husain M; Cherney DZ Circulation; 2016 Sep; 134(10):752-72. PubMed ID: 27470878 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. Paneni F; Lüscher TF Am J Cardiol; 2017 Jul; 120(1S):S17-S27. PubMed ID: 28606340 [TBL] [Abstract][Full Text] [Related]
24. Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG. Rydén L; Shahim B; Mellbin L Clin Ther; 2016 Jun; 38(6):1279-1287. PubMed ID: 27107734 [TBL] [Abstract][Full Text] [Related]
25. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies. Thrasher J Am J Cardiol; 2017 Jul; 120(1S):S4-S16. PubMed ID: 28606343 [TBL] [Abstract][Full Text] [Related]
26. DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives. Bonora E; Cigolini M Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):273-84. PubMed ID: 27038847 [TBL] [Abstract][Full Text] [Related]
27. Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications. Eleftheriadou I; Grigoropoulou P; Liberopoulos E; Liatis S; Kokkinos A; Tentolouris N Curr Med Chem; 2018; 25(13):1549-1566. PubMed ID: 28554326 [TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular protection of patients with type 2 diabetes : from EMPA-REG OUTCOME to LEADER]. Scheen AJ; Wallemacq C; Jandrain B; Ernest P Rev Med Suisse; 2016 Aug; 12(527):1370-1375. PubMed ID: 28671791 [TBL] [Abstract][Full Text] [Related]
29. Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors. Bistola V; Lambadiari V; Dimitriadis G; Ioannidis I; Makrilakis K; Tentolouris N; Tsapas A; Parissis J Heart Fail Rev; 2018 May; 23(3):377-388. PubMed ID: 29383638 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus. Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197 [TBL] [Abstract][Full Text] [Related]
32. [Analysis of cardiovascular safety of novel glucose-lowering medications]. Mkrtumyan AM; Markova TN; Mishchenko NK Kardiologiia; 2019 Jul; 59(7):76-83. PubMed ID: 31322093 [TBL] [Abstract][Full Text] [Related]
33. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Tandon N; Ali MK; Narayan KM Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193 [TBL] [Abstract][Full Text] [Related]
34. Diabetes medications and cardiovascular disease: at long last progress. Lupsa BC; Inzucchi SE Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):87-93. PubMed ID: 29369916 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective. Thompson PL; Davis TME Clin Ther; 2017 May; 39(5):1012-1025. PubMed ID: 27863704 [TBL] [Abstract][Full Text] [Related]
36. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Suissa S Diabetes Care; 2018 Jan; 41(1):6-10. PubMed ID: 29263192 [TBL] [Abstract][Full Text] [Related]
37. A review on cardiovascular effects of newer hypoglycaemic medications. Cutshall BT; Twilla JD; Olinger AS; Oliphant CS Ann Med; 2017 Nov; 49(7):603-612. PubMed ID: 28540743 [TBL] [Abstract][Full Text] [Related]
38. [Diabetes Mellitus Type 2: Recent Publications and New Drugs]. Elbelt U Dtsch Med Wochenschr; 2018 Jun; 143(11):772-776. PubMed ID: 29807374 [TBL] [Abstract][Full Text] [Related]
39. Network meta-analysis of cardiovascular outcomes in randomized controlled trials of new antidiabetic drugs. Fei Y; Tsoi MF; Kumana CR; Cheung TT; Cheung BMY Int J Cardiol; 2018 Mar; 254():291-296. PubMed ID: 29277321 [TBL] [Abstract][Full Text] [Related]
40. Update on SGLT2 Inhibitors-New Data Released at the American Diabetes Association. Lee S Crit Pathw Cardiol; 2017 Sep; 16(3):93-95. PubMed ID: 28742644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]